Lantheus Holdings Inc. (LNTH) Trading Up 7.4%
Lantheus Holdings Inc. (NASDAQ:LNTH)’s share price was up 7.4% on Friday . The company traded as high as $6.10 and last traded at $6.10, with a volume of 127,073 shares. The stock had previously closed at $5.68.
A number of equities analysts have recently weighed in on LNTH shares. Zacks Investment Research upgraded Lantheus Holdings from a “hold” rating to a “buy” rating and set a $2.25 target price on the stock in a research note on Friday, May 6th. Jefferies Group restated a “buy” rating on shares of Lantheus Holdings in a research note on Wednesday, May 4th. Finally, Credit Suisse Group AG set a $4.00 price objective on Lantheus Holdings and gave the stock a “hold” rating in a research note on Friday, August 5th. Three analysts have rated the stock with a hold rating, two have assigned a buy rating and one has given a strong buy rating to the company. Lantheus Holdings has an average rating of “Buy” and a consensus price target of $5.80.
The stock’s 50-day moving average is $4.50 and its 200 day moving average is $2.72. The firm has a market cap of $196.00 million and a P/E ratio of 7.28.
Lantheus Holdings (NASDAQ:LNTH) last announced its earnings results on Thursday, August 4th. The company reported $0.24 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.18. The business earned $78 million during the quarter, compared to analysts’ expectations of $72.66 million. Equities research analysts expect that Lantheus Holdings Inc. will post $0.48 earnings per share for the current year.
Lantheus Holdings, Inc develops, manufactures and commercializes diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. The Company’s portfolio of approximately 10 commercial products is spread across a range of imaging modalities.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.